Sleep Software Market by Function (Sleep Tracking, Analysis, Disorder Management, Improvement), Indication (Insomnia, Sleep Apnea), Offering (Platforms, Apps (Mobile)), End-user (Providers, Individual), Deployment, Type, & Region - Global Forecast to 2030
The global Sleep Software market is projected to reach USD 1,569.2 Million by 2030 from USD 878.9 million in 2024, at a CAGR of 10.1% during the forecast period. The growth in the sleep software market is driven by the shift towards preventive health since individuals and health systems are putting more emphasis on proactive wellness approaches rather than reacting to treatments. Sleep software can play a major role in such a shift by allowing users to track their sleep, spot early sleep issues, and develop healthier habits for long-term wellness. As awareness grows about the link between sleep quality and chronic conditions such as obesity, heart disease, and mental health disorders, consumers are increasingly adopting tools that help address potential issues before they become serious.
“The mobile applications segment is expected to register the fastest growth during the forecast period, by offering”
The Sleep Software market, by offering, is segmented into platforms and applications. The mobile applications segment is expected to grow the fastest during the forecast period due to the rapid growth of mobile-based applications in the sleep software market, which is driven by rising awareness of sleep health, increasing sleep disorders, and advancements in technology. Sleep apps such as Sleep Cycle, Calm, and Headspace offer features such as tracking, relaxation, and integration with wearables. Demand is further increased by stressful lives and health trends, with products such as Moshi for kids and CBT-I Coach for sleeplessness. These apps are now widely available and crucial for improved sleep management due to their affordable models and pandemic-driven mental health focus.
“Cloud-based segment dominated the sleep software market, by deployment model.”
By deployment model, the Sleep Software market is divided into on-premise models and cloud-based models. In 2023, cloud-based models, by deployment model, held a large share of the Sleep Software market. Owing to its scalability, cost efficiency, and accessibility. Cloud solutions enable easy expansion without significant infrastructure costs while providing users with real-time data synchronization across devices. The cloud platforms offer robust data security and seamless updates that continue to allow access to the latest feature upgrades. Integration capabilities with other health platforms and global reach provide an added strength in terms of dominance in the market share.
“Asia Pacific is expected to register the fastest market growth during the forecast period.”
The Sleep Software market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The sleep software market in the Asia Pacific region is being driven by growing awareness of sleep's critical role in health and productivity, with rising consumer focus on addressing issues like insomnia and sleep apnea, exacerbated by urbanization and high-stress lifestyles. The growing middle class and increasing disposable incomes in key markets such as India, China, and Indonesia fuel demand for innovative sleep solutions, including apps and wearable integrations, as consumers focus on wellness and invest in health-focused technologies.
The break-down of primary participants is as mentioned below:
1. Koninklijke Philips N.V. (Netherlands)
2. Cadwell Industries Inc. (US)
3. COMPUMEDICS LIMITED (Australia)
4. Neurovirtual. (US)
5. NIHON KOHDEN CORPORATION (Japan)
6. Nox Medical (Iceland)
7. Natus Medical Incorporated (ARCHIMED) (US)
8. RXNT (US)
9. Resmed (US)
10. Cleveland Medical Devices Inc. (US)
11. SOMNOmedics AG (Germany)
12. CIDELEC (France)
13. Calm (US)
14. Sleep Cycle (Sweden)
15. Headspace Inc. (US)
16. Lцwenstein Medical SE & Co. KG (Germany)
17. CamNtech Ltd (United Kingdom)
18. Fisher & Paykel Healthcare Limited. (New Zealand)
19. BioSerenity (France)
20. VYAIRE MEDICAL INC (US)
21. Inspire Medical Systems, Inc. (US)
22. HoneyNaps (South Korea)
23. Sleep Reset (US)
24. SleepImage. (US)
25. BigHealth (US)
26. Bodymatter, Inc. (US)
27. Neybox Digital Ltd. (US)
28. Consumer Sleep Solutions LLC. (US)
Research Coverage:
The report analyzes the sleep software market and aims to estimate the market size and future growth potential of various market segments based on type, offering, function, indication, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for stakeholders in the market. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total sleep software market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
“The mobile applications segment is expected to register the fastest growth during the forecast period, by offering”
The Sleep Software market, by offering, is segmented into platforms and applications. The mobile applications segment is expected to grow the fastest during the forecast period due to the rapid growth of mobile-based applications in the sleep software market, which is driven by rising awareness of sleep health, increasing sleep disorders, and advancements in technology. Sleep apps such as Sleep Cycle, Calm, and Headspace offer features such as tracking, relaxation, and integration with wearables. Demand is further increased by stressful lives and health trends, with products such as Moshi for kids and CBT-I Coach for sleeplessness. These apps are now widely available and crucial for improved sleep management due to their affordable models and pandemic-driven mental health focus.
“Cloud-based segment dominated the sleep software market, by deployment model.”
By deployment model, the Sleep Software market is divided into on-premise models and cloud-based models. In 2023, cloud-based models, by deployment model, held a large share of the Sleep Software market. Owing to its scalability, cost efficiency, and accessibility. Cloud solutions enable easy expansion without significant infrastructure costs while providing users with real-time data synchronization across devices. The cloud platforms offer robust data security and seamless updates that continue to allow access to the latest feature upgrades. Integration capabilities with other health platforms and global reach provide an added strength in terms of dominance in the market share.
“Asia Pacific is expected to register the fastest market growth during the forecast period.”
The Sleep Software market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The sleep software market in the Asia Pacific region is being driven by growing awareness of sleep's critical role in health and productivity, with rising consumer focus on addressing issues like insomnia and sleep apnea, exacerbated by urbanization and high-stress lifestyles. The growing middle class and increasing disposable incomes in key markets such as India, China, and Indonesia fuel demand for innovative sleep solutions, including apps and wearable integrations, as consumers focus on wellness and invest in health-focused technologies.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation - Directors: 30%, Manager: 34%, and Others: 36%
- By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3% and Middle East & Africa: 2%
1. Koninklijke Philips N.V. (Netherlands)
2. Cadwell Industries Inc. (US)
3. COMPUMEDICS LIMITED (Australia)
4. Neurovirtual. (US)
5. NIHON KOHDEN CORPORATION (Japan)
6. Nox Medical (Iceland)
7. Natus Medical Incorporated (ARCHIMED) (US)
8. RXNT (US)
9. Resmed (US)
10. Cleveland Medical Devices Inc. (US)
11. SOMNOmedics AG (Germany)
12. CIDELEC (France)
13. Calm (US)
14. Sleep Cycle (Sweden)
15. Headspace Inc. (US)
16. Lцwenstein Medical SE & Co. KG (Germany)
17. CamNtech Ltd (United Kingdom)
18. Fisher & Paykel Healthcare Limited. (New Zealand)
19. BioSerenity (France)
20. VYAIRE MEDICAL INC (US)
21. Inspire Medical Systems, Inc. (US)
22. HoneyNaps (South Korea)
23. Sleep Reset (US)
24. SleepImage. (US)
25. BigHealth (US)
26. Bodymatter, Inc. (US)
27. Neybox Digital Ltd. (US)
28. Consumer Sleep Solutions LLC. (US)
Research Coverage:
The report analyzes the sleep software market and aims to estimate the market size and future growth potential of various market segments based on type, offering, function, indication, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for stakeholders in the market. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total sleep software market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (growing incidence of sleep disorders, increasing adoption of telehealth and mhealth, increasing emphasis on corporate wellness programs, growing awareness regarding sleep apnea and wellness improvement, favorable reimbursement and financial aid for sleep apnea devices and therapies), restraints (use of alternative therapies and medications for sleep disorders, data security and privacy concerns, resistance from tradition healthcare providers), opportunities (adoption of advanced technologies, integration with wearable devices, personalized sleep solutions, mental health and wellness integration), challenges (lack of clinical validation for many solutions, regulatory compliance complexities, growing concerns about data privacy and security.) are factors contributing the growth of the sleep software market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the sleep software market.
- Market Development: Comprehensive information on the lucrative emerging markets, type, offering, function, indications, deployment model, end user, and region.
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the sleep software market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global sleep software market such as Koninklijke Philips N.V. (Netherlands), Resmed (US), Calm (US), Headspace Inc. (US), Inspire Medical Systems, Inc. (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET ESTIMATION METHODOLOGY
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 MARKET SIZING ASSUMPTIONS
2.5.2 OVERALL STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SLEEP SOFTWARE MARKET OVERVIEW
4.2 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER & REGION
4.3 SLEEP SOFTWARE MARKET: GEOGRAPHIC MIX
4.4 SLEEP SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Expansion of telehealth and remote patient monitoring
5.2.1.2 Vast population of undiagnosed sleep apnea patients
5.2.1.3 Growing awareness regarding sleep apnea and wellness improvement
5.2.1.4 Favorable reimbursement and financial aid for sleep apnea devices and therapies
5.2.1.5 Increasing emphasis on corporate wellness programs
5.2.2 RESTRAINTS
5.2.2.1 Data privacy and security concerns
5.2.2.2 Use of alternative therapies and medications for sleep disorders
5.2.2.3 Resistance from traditional healthcare providers
5.2.3 OPPORTUNITIES
5.2.3.1 Development of mHealth tools
5.2.3.2 Rising potential of AI & ML in sleep medicine
5.2.3.3 Rising demand for smart wearables
5.2.3.4 Increasing focus on mental health and wellbeing
5.2.4 CHALLENGES
5.2.4.1 Lack of clinical validation of sleep apps
5.2.4.2 Strategic challenges in monetizing sleep apps
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 INDUSTRY TRENDS
5.4.1 VALUE-BASED CARE MODELS
5.4.2 CLOUD-BASED SOLUTIONS
5.4.3 IOT AND WEARABLES
5.5 ECOSYSTEM ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Artificial intelligence & machine learning
5.7.1.2 Internet of things (IoT)
5.7.1.3 Mobile applications
5.7.1.4 Biosensors and wearable technology
5.7.1.5 Gamification technology
5.7.1.6 Voice assistants
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Smart home automation
5.7.2.2 Telemedicine platforms
5.7.2.3 Data analysis and visualization tools
5.7.2.4 EHR integration
5.7.2.5 Cloud computing
5.7.3 ADJACENT TECHNOLOGIES
5.7.3.1 Fitness trackers
5.7.3.2 Respiratory monitoring devices
5.7.3.3 Augmented reality (AR) & virtual reality (VR)
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2 REGULATORY SCENARIO
5.8.2.1 North America
5.8.2.2 Europe
5.8.2.3 Asia Pacific
5.8.2.4 Middle East & Africa
5.8.2.5 Latin America
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)
5.9.2 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)
5.10 PORTER’S FIVE FORCES ANALYSIS
5.10.1 INTENSITY OF COMPETITIVE RIVALRY
5.10.2 BARGAINING POWER OF BUYERS
5.10.3 THREAT OF SUBSTITUTES
5.10.4 THREAT OF NEW ENTRANTS
5.10.5 BARGAINING POWER OF SUPPLIERS
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE
5.11.3 MAJOR PATENTS IN SLEEP SOFTWARE MARKET
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 KEY BUYING CRITERIA
5.13 END-USER ANALYSIS
5.13.1 UNMET NEEDS
5.13.2 END-USER EXPECTATIONS
5.14 KEY CONFERENCES & EVENTS, 2025–2026
5.15 CASE STUDY ANALYSIS
5.15.1 CASE STUDY 1: TRANSFORMING SLEEP STUDY AT ST. LUKE’S SLEEP MEDICINE INSTITUTE
5.15.2 CASE STUDY 2: GRANGER MEDICAL CLINIC’S PATH TO EFFICIENT HEALTHCARE OPERATIONS
5.16 INVESTMENT & FUNDING SCENARIO
5.17 BUSINESS MODEL ANALYSIS
5.18 IMPACT OF AI/GEN AI ON SLEEP SOFTWARE MARKET
5.18.1 KEY USE CASES
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
5.18.2.1 Case study 1: Leveraging AI to drive improved patient adherence and operational efficiency at Aeroflow Sleep
5.18.2.2 Case study 2: Optimizing sleep lab workflow and enhancing patient care with EnsoSleep AI at Northwell Health
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.18.3.1 Remote patient monitoring market
5.18.3.2 Digital health market
5.18.3.3 Telehealth and telemedicine market
5.18.3.4 mHealth market
5.18.4 USER READINESS AND IMPACT ASSESSMENT
5.18.4.1 User readiness
5.18.4.1.1 User A: Individual users
5.18.4.1.2 User B: Healthcare providers
5.18.4.2 Impact assessment
5.18.4.2.1 User A: Individual users
5.18.4.2.2 User B: Healthcare providers
6 SLEEP SOFTWARE MARKET, BY TYPE
6.1 INTRODUCTION
6.2 INTEGRATED SOFTWARE
6.2.1 NEED FOR INTEGRATED SOFTWARE WITHIN BROADER HEALTH AND WELLNESS ECOSYSTEMS TO BOLSTER GROWTH
6.3 STANDALONE SOFTWARE
6.3.1 RISING TREND TOWARD MOBILE HEALTH APPLICATIONS TO INTENSIFY GROWTH
7 SLEEP SOFTWARE MARKET, BY OFFERING
7.1 INTRODUCTION
7.2 PLATFORMS
7.2.1 GROWING ADOPTION OF CONNECTED HEALTH TECHNOLOGIES TO BOOST MARKET
7.3 APPLICATIONS
7.3.1 MOBILE APPLICATIONS
7.3.1.1 Increasing penetration of smartphones and consumer demand for on-the-go health monitoring tools to aid growth
7.3.2 DESKTOP APPLICATIONS
7.3.2.1 Need for advanced solutions to address sleep issues and improve sleep quality to expedite growth
8 SLEEP SOFTWARE MARKET, BY FUNCTION
8.1 INTRODUCTION
8.2 SLEEP TRACKING
8.2.1 RISING HEALTH AWARENESS ABOUT IMPORTANCE OF SLEEP TO FACILITATE GROWTH
8.3 SLEEP IMPROVEMENT
8.3.1 INCREASING PREFERENCE FOR NON-INVASIVE SOLUTIONS FOR SLEEP IMPROVEMENT TO FAVOR GROWTH
8.4 SLEEP ANALYSIS
8.4.1 GROWING INTEGRATION OF SLEEP ANALYSIS TOOLS INTO WEARABLES TO FUEL MARKET
8.5 SLEEP DISORDER MANAGEMENT
8.5.1 INCREASING RESEARCH ON SLEEP DISORDER DIAGNOSTICS TO SUPPORT GROWTH
9 SLEEP SOFTWARE MARKET, BY INDICATION
9.1 INTRODUCTION
9.2 INSOMNIA
9.2.1 RISING MENTAL HEALTH ISSUES AND DEMAND FOR NON-PHARMACOLOGICAL TREATMENTS TO AID GROWTH
9.3 SLEEP APNEA
9.3.1 GROWING PATIENT SHIFT TO DIGITAL SOLUTIONS TO BOOST MARKET
9.4 GENERAL SLEEP IMPROVEMENT
9.4.1 RISE IN HEALTH CONSCIOUSNESS AMONG CONSUMERS TO AUGMENT GROWTH
9.5 OTHER INDICATIONS
10 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL
10.1 INTRODUCTION
10.2 ON-PREMISE MODELS
10.2.1 NEED FOR ENHANCED DATA CONTROL, SECURITY, AND COMPLIANCE TO PROMOTE GROWTH
10.3 CLOUD-BASED MODELS
10.3.1 GROWING ADOPTION OF REMOTE PATIENT MONITORING SYSTEMS TO DRIVE MARKET
11 SLEEP SOFTWARE MARKET, BY END USER
11.1 INTRODUCTION
11.2 INDIVIDUAL USERS
11.2.1 GROWING AWARENESS OF SLEEP HEALTH AND ADOPTION OF WEARABLE TRACKERS TO PROPEL MARKET
11.3 HEALTHCARE PROVIDERS
11.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN SLEEP SOFTWARE TO DRIVE MARKET
11.4 OTHER END USERS
12 SLEEP SOFTWARE MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 Increasing investments due to reduced workplace productivity and decreased quality of life to drive market
12.2.3 CANADA
12.2.3.1 Government investments and increasing awareness to drive market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Growing need for effective diagnostic and treatment solutions to drive market
12.3.3 UK
12.3.3.1 Rising interest in sleep management apps to favor market
12.3.4 FRANCE
12.3.4.1 Rising awareness and supportive government initiatives to fuel market growth
12.3.5 ITALY
12.3.5.1 Growing insomnia prevalence in Italy to propel market
12.3.6 SPAIN
12.3.6.1 Increasing incidence of sleep problems in younger populations to drive demand
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Rising sleep disorder prevalence to drive market
12.4.3 INDIA
12.4.3.1 Collaborative efforts with other countries to support market growth
12.4.4 JAPAN
12.4.4.1 Need for digital solutions and government initiatives to drive market
12.4.5 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Rising cases of sleep disorders among older adults to drive market
12.5.3 MEXICO
12.5.3.1 Socioeconomic factors and environmental stressors to support market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Rising obesity rate to drive demand for sleep disorder treatment solutions in GCC countries
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP SOFTWARE MARKET
13.3 REVENUE ANALYSIS, 2019–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Offering footprint
13.5.5.5 Function footprint
13.5.5.6 Indication footprint
13.5.5.7 Deployment footprint
13.5.5.8 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.8 BRAND/SOFTWARE COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 CALM
14.1.1.1 Business overview
14.1.1.2 Solutions offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 HEADSPACE INC.
14.1.2.1 Business overview
14.1.2.2 Solutions offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 RESMED
14.1.3.1 Business overview
14.1.3.2 Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Product enhancements
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 KONINKLIJKE PHILIPS N.V.
14.1.4.1 Business overview
14.1.4.2 Solutions offered
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses & competitive threats
14.1.5 INSPIRE MEDICAL SYSTEMS, INC.
14.1.5.1 Business overview
14.1.5.2 Solutions offered
14.1.5.3 MnM view
14.1.5.3.1 Right to win
14.1.5.3.2 Strategic choices
14.1.5.3.3 Weaknesses & competitive threats
14.1.6 CADWELL INDUSTRIES INC.
14.1.6.1 Business overview
14.1.6.2 Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.7 COMPUMEDICS LIMITED
14.1.7.1 Business overview
14.1.7.2 Solutions offered
14.1.8 NEUROVIRTUAL
14.1.8.1 Business overview
14.1.8.2 Solutions offered
14.1.8.3 Recent developments
14.1.8.3.1 Expansions
14.1.9 NIHON KOHDEN CORPORATION
14.1.9.1 Business overview
14.1.9.2 Solutions offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Expansions
14.1.10 NOX MEDICAL
14.1.10.1 Business overview
14.1.10.2 Solutions offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches & enhancements
14.1.11 NATUS MEDICAL INCORPORATED
14.1.11.1 Business overview
14.1.11.2 Solutions offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.12 RXNT
14.1.12.1 Business overview
14.1.12.2 Solutions offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.13 CLEVELAND MEDICAL DEVICES INC.
14.1.13.1 Business overview
14.1.13.2 Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Product enhancements
14.1.14 SOMNOMEDICS AG
14.1.14.1 Business overview
14.1.14.2 Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Deals
14.1.15 CIDELEC
14.1.15.1 Business overview
14.1.15.2 Solutions offered
14.1.16 SLEEP CYCLE
14.1.16.1 Business overview
14.1.16.2 Solutions offered
14.1.16.3 Recent developments
14.1.16.3.1 Product launches
14.1.16.3.2 Deals
14.1.17 LЦWENSTEIN MEDICAL SE & CO. KG
14.1.17.1 Business overview
14.1.17.2 Solutions offered
14.1.18 CAMNTECH LTD.
14.1.18.1 Business overview
14.1.18.2 Solutions offered
14.1.18.3 Recent developments
14.1.18.3.1 Product launches
14.1.19 FISHER & PAYKEL HEALTHCARE LIMITED
14.1.19.1 Business overview
14.1.19.2 Solutions offered
14.1.19.3 Recent developments
14.1.19.3.1 Product launches
14.1.19.3.2 Expansions
14.1.20 BIOSERENITY
14.1.20.1 Business overview
14.1.20.2 Solutions offered
14.1.20.3 Recent developments
14.1.20.3.1 Other developments
14.1.21 VYAIRE MEDICAL, INC.
14.1.21.1 Business overview
14.1.21.2 Solutions offered
14.2 OTHER PLAYERS
14.2.1 HONEYNAPS
14.2.2 SLEEPIMAGE
14.2.3 SLEEP RESET
14.2.4 BIGHEALTH
14.2.5 BODYMATTER, INC.
14.2.6 NEYBOX DIGITAL LTD.
14.2.7 CONSUMER SLEEP SOLUTIONS LLC
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET ESTIMATION METHODOLOGY
2.3 MARKET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 MARKET SIZING ASSUMPTIONS
2.5.2 OVERALL STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 SLEEP SOFTWARE MARKET OVERVIEW
4.2 NORTH AMERICA: SLEEP SOFTWARE MARKET, BY END USER & REGION
4.3 SLEEP SOFTWARE MARKET: GEOGRAPHIC MIX
4.4 SLEEP SOFTWARE MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Expansion of telehealth and remote patient monitoring
5.2.1.2 Vast population of undiagnosed sleep apnea patients
5.2.1.3 Growing awareness regarding sleep apnea and wellness improvement
5.2.1.4 Favorable reimbursement and financial aid for sleep apnea devices and therapies
5.2.1.5 Increasing emphasis on corporate wellness programs
5.2.2 RESTRAINTS
5.2.2.1 Data privacy and security concerns
5.2.2.2 Use of alternative therapies and medications for sleep disorders
5.2.2.3 Resistance from traditional healthcare providers
5.2.3 OPPORTUNITIES
5.2.3.1 Development of mHealth tools
5.2.3.2 Rising potential of AI & ML in sleep medicine
5.2.3.3 Rising demand for smart wearables
5.2.3.4 Increasing focus on mental health and wellbeing
5.2.4 CHALLENGES
5.2.4.1 Lack of clinical validation of sleep apps
5.2.4.2 Strategic challenges in monetizing sleep apps
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 INDUSTRY TRENDS
5.4.1 VALUE-BASED CARE MODELS
5.4.2 CLOUD-BASED SOLUTIONS
5.4.3 IOT AND WEARABLES
5.5 ECOSYSTEM ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Artificial intelligence & machine learning
5.7.1.2 Internet of things (IoT)
5.7.1.3 Mobile applications
5.7.1.4 Biosensors and wearable technology
5.7.1.5 Gamification technology
5.7.1.6 Voice assistants
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Smart home automation
5.7.2.2 Telemedicine platforms
5.7.2.3 Data analysis and visualization tools
5.7.2.4 EHR integration
5.7.2.5 Cloud computing
5.7.3 ADJACENT TECHNOLOGIES
5.7.3.1 Fitness trackers
5.7.3.2 Respiratory monitoring devices
5.7.3.3 Augmented reality (AR) & virtual reality (VR)
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2 REGULATORY SCENARIO
5.8.2.1 North America
5.8.2.2 Europe
5.8.2.3 Asia Pacific
5.8.2.4 Middle East & Africa
5.8.2.5 Latin America
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF SLEEP APPS, BY KEY PLAYER (2023)
5.9.2 AVERAGE SELLING PRICE OF SLEEP APPS, BY REGION (2023)
5.10 PORTER’S FIVE FORCES ANALYSIS
5.10.1 INTENSITY OF COMPETITIVE RIVALRY
5.10.2 BARGAINING POWER OF BUYERS
5.10.3 THREAT OF SUBSTITUTES
5.10.4 THREAT OF NEW ENTRANTS
5.10.5 BARGAINING POWER OF SUPPLIERS
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS
5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SLEEP SOFTWARE
5.11.3 MAJOR PATENTS IN SLEEP SOFTWARE MARKET
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 KEY BUYING CRITERIA
5.13 END-USER ANALYSIS
5.13.1 UNMET NEEDS
5.13.2 END-USER EXPECTATIONS
5.14 KEY CONFERENCES & EVENTS, 2025–2026
5.15 CASE STUDY ANALYSIS
5.15.1 CASE STUDY 1: TRANSFORMING SLEEP STUDY AT ST. LUKE’S SLEEP MEDICINE INSTITUTE
5.15.2 CASE STUDY 2: GRANGER MEDICAL CLINIC’S PATH TO EFFICIENT HEALTHCARE OPERATIONS
5.16 INVESTMENT & FUNDING SCENARIO
5.17 BUSINESS MODEL ANALYSIS
5.18 IMPACT OF AI/GEN AI ON SLEEP SOFTWARE MARKET
5.18.1 KEY USE CASES
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
5.18.2.1 Case study 1: Leveraging AI to drive improved patient adherence and operational efficiency at Aeroflow Sleep
5.18.2.2 Case study 2: Optimizing sleep lab workflow and enhancing patient care with EnsoSleep AI at Northwell Health
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.18.3.1 Remote patient monitoring market
5.18.3.2 Digital health market
5.18.3.3 Telehealth and telemedicine market
5.18.3.4 mHealth market
5.18.4 USER READINESS AND IMPACT ASSESSMENT
5.18.4.1 User readiness
5.18.4.1.1 User A: Individual users
5.18.4.1.2 User B: Healthcare providers
5.18.4.2 Impact assessment
5.18.4.2.1 User A: Individual users
5.18.4.2.2 User B: Healthcare providers
6 SLEEP SOFTWARE MARKET, BY TYPE
6.1 INTRODUCTION
6.2 INTEGRATED SOFTWARE
6.2.1 NEED FOR INTEGRATED SOFTWARE WITHIN BROADER HEALTH AND WELLNESS ECOSYSTEMS TO BOLSTER GROWTH
6.3 STANDALONE SOFTWARE
6.3.1 RISING TREND TOWARD MOBILE HEALTH APPLICATIONS TO INTENSIFY GROWTH
7 SLEEP SOFTWARE MARKET, BY OFFERING
7.1 INTRODUCTION
7.2 PLATFORMS
7.2.1 GROWING ADOPTION OF CONNECTED HEALTH TECHNOLOGIES TO BOOST MARKET
7.3 APPLICATIONS
7.3.1 MOBILE APPLICATIONS
7.3.1.1 Increasing penetration of smartphones and consumer demand for on-the-go health monitoring tools to aid growth
7.3.2 DESKTOP APPLICATIONS
7.3.2.1 Need for advanced solutions to address sleep issues and improve sleep quality to expedite growth
8 SLEEP SOFTWARE MARKET, BY FUNCTION
8.1 INTRODUCTION
8.2 SLEEP TRACKING
8.2.1 RISING HEALTH AWARENESS ABOUT IMPORTANCE OF SLEEP TO FACILITATE GROWTH
8.3 SLEEP IMPROVEMENT
8.3.1 INCREASING PREFERENCE FOR NON-INVASIVE SOLUTIONS FOR SLEEP IMPROVEMENT TO FAVOR GROWTH
8.4 SLEEP ANALYSIS
8.4.1 GROWING INTEGRATION OF SLEEP ANALYSIS TOOLS INTO WEARABLES TO FUEL MARKET
8.5 SLEEP DISORDER MANAGEMENT
8.5.1 INCREASING RESEARCH ON SLEEP DISORDER DIAGNOSTICS TO SUPPORT GROWTH
9 SLEEP SOFTWARE MARKET, BY INDICATION
9.1 INTRODUCTION
9.2 INSOMNIA
9.2.1 RISING MENTAL HEALTH ISSUES AND DEMAND FOR NON-PHARMACOLOGICAL TREATMENTS TO AID GROWTH
9.3 SLEEP APNEA
9.3.1 GROWING PATIENT SHIFT TO DIGITAL SOLUTIONS TO BOOST MARKET
9.4 GENERAL SLEEP IMPROVEMENT
9.4.1 RISE IN HEALTH CONSCIOUSNESS AMONG CONSUMERS TO AUGMENT GROWTH
9.5 OTHER INDICATIONS
10 SLEEP SOFTWARE MARKET, BY DEPLOYMENT MODEL
10.1 INTRODUCTION
10.2 ON-PREMISE MODELS
10.2.1 NEED FOR ENHANCED DATA CONTROL, SECURITY, AND COMPLIANCE TO PROMOTE GROWTH
10.3 CLOUD-BASED MODELS
10.3.1 GROWING ADOPTION OF REMOTE PATIENT MONITORING SYSTEMS TO DRIVE MARKET
11 SLEEP SOFTWARE MARKET, BY END USER
11.1 INTRODUCTION
11.2 INDIVIDUAL USERS
11.2.1 GROWING AWARENESS OF SLEEP HEALTH AND ADOPTION OF WEARABLE TRACKERS TO PROPEL MARKET
11.3 HEALTHCARE PROVIDERS
11.3.1 RISING TECHNOLOGICAL ADVANCEMENTS IN SLEEP SOFTWARE TO DRIVE MARKET
11.4 OTHER END USERS
12 SLEEP SOFTWARE MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 US
12.2.2.1 Increasing investments due to reduced workplace productivity and decreased quality of life to drive market
12.2.3 CANADA
12.2.3.1 Government investments and increasing awareness to drive market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 GERMANY
12.3.2.1 Growing need for effective diagnostic and treatment solutions to drive market
12.3.3 UK
12.3.3.1 Rising interest in sleep management apps to favor market
12.3.4 FRANCE
12.3.4.1 Rising awareness and supportive government initiatives to fuel market growth
12.3.5 ITALY
12.3.5.1 Growing insomnia prevalence in Italy to propel market
12.3.6 SPAIN
12.3.6.1 Increasing incidence of sleep problems in younger populations to drive demand
12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 CHINA
12.4.2.1 Rising sleep disorder prevalence to drive market
12.4.3 INDIA
12.4.3.1 Collaborative efforts with other countries to support market growth
12.4.4 JAPAN
12.4.4.1 Need for digital solutions and government initiatives to drive market
12.4.5 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 BRAZIL
12.5.2.1 Rising cases of sleep disorders among older adults to drive market
12.5.3 MEXICO
12.5.3.1 Socioeconomic factors and environmental stressors to support market growth
12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 GCC COUNTRIES
12.6.2.1 Rising obesity rate to drive demand for sleep disorder treatment solutions in GCC countries
12.6.3 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP SOFTWARE MARKET
13.3 REVENUE ANALYSIS, 2019–2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Type footprint
13.5.5.4 Offering footprint
13.5.5.5 Function footprint
13.5.5.6 Indication footprint
13.5.5.7 Deployment footprint
13.5.5.8 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
13.8 BRAND/SOFTWARE COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 CALM
14.1.1.1 Business overview
14.1.1.2 Solutions offered
14.1.1.3 Recent developments
14.1.1.3.1 Deals
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 HEADSPACE INC.
14.1.2.1 Business overview
14.1.2.2 Solutions offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 RESMED
14.1.3.1 Business overview
14.1.3.2 Solutions offered
14.1.3.3 Recent developments
14.1.3.3.1 Product enhancements
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses & competitive threats
14.1.4 KONINKLIJKE PHILIPS N.V.
14.1.4.1 Business overview
14.1.4.2 Solutions offered
14.1.4.3 MnM view
14.1.4.3.1 Right to win
14.1.4.3.2 Strategic choices
14.1.4.3.3 Weaknesses & competitive threats
14.1.5 INSPIRE MEDICAL SYSTEMS, INC.
14.1.5.1 Business overview
14.1.5.2 Solutions offered
14.1.5.3 MnM view
14.1.5.3.1 Right to win
14.1.5.3.2 Strategic choices
14.1.5.3.3 Weaknesses & competitive threats
14.1.6 CADWELL INDUSTRIES INC.
14.1.6.1 Business overview
14.1.6.2 Solutions offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.7 COMPUMEDICS LIMITED
14.1.7.1 Business overview
14.1.7.2 Solutions offered
14.1.8 NEUROVIRTUAL
14.1.8.1 Business overview
14.1.8.2 Solutions offered
14.1.8.3 Recent developments
14.1.8.3.1 Expansions
14.1.9 NIHON KOHDEN CORPORATION
14.1.9.1 Business overview
14.1.9.2 Solutions offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Expansions
14.1.10 NOX MEDICAL
14.1.10.1 Business overview
14.1.10.2 Solutions offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches & enhancements
14.1.11 NATUS MEDICAL INCORPORATED
14.1.11.1 Business overview
14.1.11.2 Solutions offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.12 RXNT
14.1.12.1 Business overview
14.1.12.2 Solutions offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches
14.1.13 CLEVELAND MEDICAL DEVICES INC.
14.1.13.1 Business overview
14.1.13.2 Solutions offered
14.1.13.3 Recent developments
14.1.13.3.1 Product enhancements
14.1.14 SOMNOMEDICS AG
14.1.14.1 Business overview
14.1.14.2 Solutions offered
14.1.14.3 Recent developments
14.1.14.3.1 Deals
14.1.15 CIDELEC
14.1.15.1 Business overview
14.1.15.2 Solutions offered
14.1.16 SLEEP CYCLE
14.1.16.1 Business overview
14.1.16.2 Solutions offered
14.1.16.3 Recent developments
14.1.16.3.1 Product launches
14.1.16.3.2 Deals
14.1.17 LЦWENSTEIN MEDICAL SE & CO. KG
14.1.17.1 Business overview
14.1.17.2 Solutions offered
14.1.18 CAMNTECH LTD.
14.1.18.1 Business overview
14.1.18.2 Solutions offered
14.1.18.3 Recent developments
14.1.18.3.1 Product launches
14.1.19 FISHER & PAYKEL HEALTHCARE LIMITED
14.1.19.1 Business overview
14.1.19.2 Solutions offered
14.1.19.3 Recent developments
14.1.19.3.1 Product launches
14.1.19.3.2 Expansions
14.1.20 BIOSERENITY
14.1.20.1 Business overview
14.1.20.2 Solutions offered
14.1.20.3 Recent developments
14.1.20.3.1 Other developments
14.1.21 VYAIRE MEDICAL, INC.
14.1.21.1 Business overview
14.1.21.2 Solutions offered
14.2 OTHER PLAYERS
14.2.1 HONEYNAPS
14.2.2 SLEEPIMAGE
14.2.3 SLEEP RESET
14.2.4 BIGHEALTH
14.2.5 BODYMATTER, INC.
14.2.6 NEYBOX DIGITAL LTD.
14.2.7 CONSUMER SLEEP SOLUTIONS LLC
15 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
